scispace - formally typeset
M

Matthias Becker

Researcher at German Center for Neurodegenerative Diseases

Publications -  54
Citations -  1734

Matthias Becker is an academic researcher from German Center for Neurodegenerative Diseases. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 10, co-authored 45 publications receiving 847 citations. Previous affiliations of Matthias Becker include University of Geneva & University of Bonn.

Papers
More filters
Journal ArticleDOI

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

Jonas Schulte-Schrepping, +137 more
- 17 Sep 2020 - 
TL;DR: This study provides detailed insights into the systemic immune response to SARS-CoV-2 infection and it reveals profound alterations in the myeloid cell compartment associated with severe COVID-19.
Journal ArticleDOI

Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.

TL;DR: This article performed RNA-seq of whole blood cell transcriptomes and granulocyte preparations from mild and severe COVID-19 patients and analyzed the data using a combination of conventional and data-driven co-expression analysis.
Posted ContentDOI

Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

TL;DR: Comparison of COVID-19 blood transcriptomes with those of a collection of over 2,600 samples derived from 11 different viral infections, inflammatory diseases and independent control samples revealed highly specific transcriptome signatures for CO VID-19, which predicted patient subgroup-specific drug candidates targeting the dysregulated systemic immune response of the host.
Journal ArticleDOI

Model-based segmentation in orbital volume measurement with cone beam computed tomography and evaluation against current concepts

TL;DR: All three orbital volume measurement methods examined can accurately measure orbital volume, although atlas-based and model-based methods seem to be more user-friendly and less time-consuming.
Journal ArticleDOI

Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood Transcriptomics.

TL;DR: The results support the notion that transcriptomics combined with machine learning could be used as part of an integrated -omics approach wherein risk prediction, differential diagnosis, and subclassification of AML are achieved by genomics while diagnosis could be assisted by transcriptomic-based machine learning.